These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33572433)

  • 1. In Vitro and In Vivo Efficacy of a Novel Glucose-Methotrexate Conjugate in Targeted Cancer Treatment.
    Woźniak M; Pastuch-Gawołek G; Makuch S; Wiśniewski J; Krenács T; Hamar P; Gamian A; Szeja W; Szkudlarek D; Krawczyk M; Agrawal S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy.
    Ciekot J; Psurski M; Jurec K; Boratyński J
    Invest New Drugs; 2021 Feb; 39(1):15-23. PubMed ID: 32643014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.
    Woźniak M; Makuch S; Pastuch-Gawołek G; Wiśniewski J; Szeja W; Nowak M; Krawczyk M; Agrawal S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
    Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
    Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
    Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
    Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
    Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
    AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
    Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
    PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
    Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
    J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
    Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
    Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
    Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
    J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
    Iwaki M; Shimada H; Irino Y; Take M; Egashira S
    Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone.
    McTavish H; Griffin RJ; Terai K; Dudek AZ
    Transl Res; 2009 Jun; 153(6):275-82. PubMed ID: 19446281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreducible cross-linked core polymer micelles enhance in vitro activity of methotrexate in breast cancer cells.
    Gulfam M; Matini T; Monteiro PF; Riva R; Collins H; Spriggs K; Howdle SM; Jérôme C; Alexander C
    Biomater Sci; 2017 Feb; 5(3):532-550. PubMed ID: 28124699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system.
    Peruzynska M; Szelag S; Trzeciak K; Kurzawski M; Cendrowski K; Barylak M; Roginska D; Piotrowska K; Mijowska E; Drozdzik M
    Int J Pharm; 2016 Jun; 506(1-2):458-68. PubMed ID: 27032563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.
    Stapf M; Pömpner N; Teichgräber U; Hilger I
    Int J Nanomedicine; 2016; 11():485-500. PubMed ID: 26893557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.
    Zhu M; Chen S; Hua L; Zhang C; Chen M; Chen D; Dong Y; Zhang Y; Li M; Song X; Chen H; Zheng H
    Nanomedicine (Lond); 2017 Feb; 12(4):295-315. PubMed ID: 28093940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice.
    Ito T; Hagiwara A; Takagi T; Fujiyama J; Sonoyama Y; Shimomura K; Takemura M; Toma A; Kin S; Nakase Y; Yamagishi H
    Anticancer Res; 2003; 23(2B):1401-4. PubMed ID: 12820401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.